Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab versus etanercept in high-need moderate to severe chronic plaque psoriasis
2008-007492-24Phase 4Active
- Sponsor
- Academic Medical Center
- Start
- Jan 2009
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial in psoriasis and plaque psoriasis comparing Infliximab with Etanercept (2 arms). Primary endpoints: Clinical efficacy, Patient-reported outcomes and 1 more. Started Jan 2009; status: active.
02
Drugs
infliximabetanercept
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on 2008-007492-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007492-24.